| 今开：3.18 | 昨收：3.2 |
| 最高：3.216 | 最低：3.11 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2.23053582E8 |
Ovid Therapeutics(OVID)02-27 06:55
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003956 Size: 5 KB 网页链接查看全文
Ovid Therapeutics(OVID)02-27 07:05
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003962 Size: 5 KB 网页链接查看全文
Ovid Therapeutics(OVID)02-27 07:05
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003966 Size: 7 KB 网页链接查看全文
Ovid Therapeutics(OVID)02-27 07:05
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003964 Size: 5 KB 网页链接查看全文
Ovid Therapeutics(OVID)今天 05:05
$Ovid Therapeutics(OVID)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-047676 Act: 34 Size: 1 MB 网页链接查看全文
Ovid Therapeutics(OVID)02-15 05:25
$Ovid Therapeutics(OVID)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001415889-24-003721 Size: 5 KB 网页链接查看全文
Ovid Therapeutics(OVID)02-27 07:05
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003968 Size: 5 KB 网页链接查看全文
Ovid Therapeutics(OVID)02-27 07:05
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003958 Size: 5 KB 网页链接查看全文
Ovid Therapeutics(OVID)今天 05:05
$Ovid Therapeutics(OVID)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-047688 Act: 34 Size: 2 MB 网页链接查看全文
Ovid Therapeutics(OVID)02-12 20:05
$Ovid Therapeutics(OVID)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-013559 Act: 34 Size: 71 KB 网页链接查看全文
Ovid Therapeutics(OVID.O)盘前拉升，涨超6%。 网页链接
$Ovid Therapeutics(OVID)$ DEF 14A Other definitive proxy statements Accession Number: 0000950170-24-047673 Act: 34 Size: 6 MB 网页链接
$Ovid Therapeutics(OVID)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0000950170-24-047676 Act: 34 Size: 1 MB 网页链接
$Ovid Therapeutics(OVID)$ ARS Annual Report to Security Holders Accession Number: 0000950170-24-047688 Act: 34 Size: 2 MB 网页链接
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-005001 Size: 6 KB 网页链接
$Ovid Therapeutics(OVID)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-24-009809 Act: 34 Size: 32 MB 网页链接
$Ovid Therapeutics(OVID)$ 8-K Current report, item 2.02 Accession Number: 0001628280-24-009807 Act: 34 Size: 275 KB 网页链接
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003972 Size: 7 KB 网页链接
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003958 Size: 5 KB 网页链接
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003966 Size: 7 KB 网页链接
$Ovid Therapeutics(OVID)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-24-003960 Size: 5 KB 网页链接